Preclinical Assessment in Juvenile Sheep of an Allogeneic Bone Tissue Engineering Product with Wharton’s Jelly Mesenchymal Stromal Cells
Secondary osteonecrosis (ON) is a common complication in paediatric cancer survivors. Combining multipotent mesenchymal stromal cells (MSCs) with core decompression surgery halts disease progression and stimulates bone regeneration. However, the success of advanced therapy medicinal products (ATMPs)...
Saved in:
Main Authors: | Raquel Cabrera-Pérez, Irene Carreras-Sánchez, Ángela Roig-Molina, Alba López-Fernández, Irene Portas-Torres, Laura Batlle-Morera, Roberto Vélez, Joaquim Vives |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/14/12/862 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KORELASI LUAS AREA WHARTON’S JELLY DENGAN LUARAN BERAT LAHIR BAYI PADA KEHAMILAN CUKUP BULAN
by: Alem Pramudita Wibowo, et al.
Published: (2017-06-01) -
Osteogenic induction of human Wharton’s jelly‐derived mesenchymal stem cells using a composite scaffold from poly(ɛ‐caprolactone) and biosilica sponge Xestospongia testudinaria
by: Andika Ardiyansyah, et al.
Published: (2025-06-01) -
Decellularized cartilage scaffolds derived from wharton's jelly facilitate cartilage regeneration and inhibit angiogenesis
by: Fawei Gao, et al.
Published: (2025-08-01) -
ROLE OF MESENCHYMAL MULTIPOTENT STROMAL CELLS IN REMODELING OF BONE DEFECTS
by: M. V. Kiselevsky, et al.
Published: (2018-06-01) -
Results of biochemical and histological studies after restoration of bone defects using cellular technologies in dental patients
by: A.V. Bambuliak, et al.
Published: (2024-06-01)